Show simple item record

dc.contributor.authorJanet Chance-Hetzler
dc.contributor.authorJane Armer
dc.contributor.authorMaggie Van Loo
dc.contributor.authorBlake Anderson
dc.contributor.authorRobin Harris
dc.contributor.authorRebecca Ewing
dc.contributor.authorBob Stewart
dc.date.accessioned2019-10-24T09:24:43Z
dc.date.available2019-10-24T09:24:43Z
dc.date.created2017-02-28 00:14
dc.date.issued2015-08-01
dc.identifieroai:doaj.org/article:57226659d8f04b8588c137b3b16126ba
dc.identifier2075-4426
dc.identifier10.3390/jpm5030311
dc.identifierhttps://doaj.org/article/57226659d8f04b8588c137b3b16126ba
dc.identifier.urihttp://hdl.handle.net/20.500.12424/923976
dc.description.abstractThe potential impact of breast cancer-related lymphedema (LE) is quite extensive, yet it often remains under-diagnosed until the later stages. This project examines the effectiveness of prospective surveillance in post-surgical breast cancer patients. A retrospective analysis of 49 out of 100 patients enrolled in a longitudinal prospective study at a Midwestern breast center evaluates: (1) time required for completion of bilateral limb measurements and Lymphedema Breast Cancer Questionnaire (LBCQ); (2) referral to LE management with limb volume increase (LVI) and/or LBCQ symptoms; and (3) cost of LE management at lower LVI (≥5%–≤10%) versus traditional (≥10%). Findings revealed a visit timeframe mean of 40.3 min (range = 25–60); 43.6% of visits were ≤30-min timeframe. Visit and measurement times decreased as clinic staff gained measurement experience; measurement time mean was 17.9 min (range = 16.9–18.9). LBCQ symptoms and LVI were significantly (p < 0.001) correlated to LE referral; six of the nine patients referred (67%) displayed both LBCQ symptoms/LVI. Visits with no symptoms reported did not result in referral, demonstrating the importance of using both indicators when assessing early LE. Lower threshold referral provides compelling evidence of potential cost savings over traditional threshold referral with reported costs of: $3755.00 and $6353.00, respectively (40.9% savings).
dc.languageEnglish
dc.publisherMultidisciplinary Digital Publishing Institute
dc.relation.ispartofhttp://www.mdpi.com/2075-4426/5/3/311
dc.relation.ispartofhttps://doaj.org/toc/2075-4426
dc.rightsCC BY
dc.sourceJournal of Personalized Medicine, Vol 5, Iss 3, Pp 311-325 (2015)
dc.subjectlymphedema
dc.subjectsurveillance
dc.subjectcost
dc.subjectreferral
dc.subjectMedicine (General)
dc.subjectR5-920
dc.subjectMedicine
dc.subjectR
dc.titleProspective Lymphedema Surveillance in a Clinic Setting
dc.typeArticle
ge.collectioncodeOAIDATA
ge.dataimportlabelOAI metadata object
ge.identifier.legacyglobethics:10536958
ge.identifier.permalinkhttps://www.globethics.net/gtl/10536958
ge.lastmodificationdate2017-02-28 00:14
ge.lastmodificationuseradmin@pointsoftware.ch (import)
ge.submissions0
ge.oai.exportid149000
ge.oai.repositoryid52
ge.oai.setnameLCC:Medicine (General)
ge.oai.setnameLCC:Medicine
ge.oai.setspecTENDOk1lZGljaW5lIChHZW5lcmFsKQ~~
ge.oai.setspecTENDOk1lZGljaW5l
ge.oai.streamid5
ge.setnameGlobeTheoLib
ge.setspecglobetheolib
ge.linkhttps://doaj.org/article/57226659d8f04b8588c137b3b16126ba


This item appears in the following Collection(s)

Show simple item record